Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted R Mikuls

Showing results (111-120 of 387) with videos related to

Pageof 39
Sort By:
Arthritis Care & Research|June 1, 2020
Incidence, Prevalence, and Burden of Gout in the Veterans Health AdministrationLindsay N Helget, Bryant R England, Punyasha Roul, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2015
Impact of Total Knee Arthroplasty as Assessed Using Patient-Reported Pain and Health-Related Quality of Life Indices: Rheumatoid Arthritis Versus OsteoarthritisAnand Dusad, Sofia Pedro, Ted R Mikuls, et al.
Scientific Reports|October 19, 2024
Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulatorsConcepcion Sanchez, Anaamika Campeau, Ru Liu-Bryan, et al.
Immunogenetics|February 12, 2014
CASPASE-12 and rheumatoid arthritis in African-AmericansLaura Marshall, Mohammad Obaidullah, Trista Fuchs, et al.
Arthritis and Rheumatism|September 30, 2008
Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolaseKarin Lundberg, Andrew Kinloch, Benjamin A Fisher, et al.
ACR Open Rheumatology|September 2, 2023
Changes in Patterns of Use of Advanced Therapies Following Emerging Data About Adverse Events in Patients With Rheumatoid Arthritis From the Veterans Affairs Health SystemStephanie Jeong, Michael D George, Ted R Mikuls, et al.
Arthritis and Rheumatism|February 13, 2013
Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung diseaseLisa Harlow, Ivan O Rosas, Bernadette R Gochuico, et al.
The Journal of Rheumatology|June 18, 2013
Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritisMarshall L R Davis, Kaleb Michaud, Harlan Sayles, et al.
World Journal of Diabetes|March 14, 2018
Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritisPatrick R Wood, Evan Manning, Joshua F Baker, et al.
The Journal of Rheumatology|December 17, 2014
Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare systemNazia Rashid, Brian W Coburn, Yi-Lin Wu, et al.
Pageof 39

Showing results (111-120 of 387) with videos related to

Sort By:
Pageof 39
Arthritis Care & Research|June 1, 2020
Incidence, Prevalence, and Burden of Gout in the Veterans Health AdministrationLindsay N Helget, Bryant R England, Punyasha Roul, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2015
Impact of Total Knee Arthroplasty as Assessed Using Patient-Reported Pain and Health-Related Quality of Life Indices: Rheumatoid Arthritis Versus OsteoarthritisAnand Dusad, Sofia Pedro, Ted R Mikuls, et al.
Scientific Reports|October 19, 2024
Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement and inflammation modulatorsConcepcion Sanchez, Anaamika Campeau, Ru Liu-Bryan, et al.
Immunogenetics|February 12, 2014
CASPASE-12 and rheumatoid arthritis in African-AmericansLaura Marshall, Mohammad Obaidullah, Trista Fuchs, et al.
Arthritis and Rheumatism|September 30, 2008
Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolaseKarin Lundberg, Andrew Kinloch, Benjamin A Fisher, et al.
ACR Open Rheumatology|September 2, 2023
Changes in Patterns of Use of Advanced Therapies Following Emerging Data About Adverse Events in Patients With Rheumatoid Arthritis From the Veterans Affairs Health SystemStephanie Jeong, Michael D George, Ted R Mikuls, et al.
Arthritis and Rheumatism|February 13, 2013
Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung diseaseLisa Harlow, Ivan O Rosas, Bernadette R Gochuico, et al.
The Journal of Rheumatology|June 18, 2013
Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritisMarshall L R Davis, Kaleb Michaud, Harlan Sayles, et al.
World Journal of Diabetes|March 14, 2018
Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritisPatrick R Wood, Evan Manning, Joshua F Baker, et al.
The Journal of Rheumatology|December 17, 2014
Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare systemNazia Rashid, Brian W Coburn, Yi-Lin Wu, et al.
Pageof 39